Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Recommendations for Infantile-Onset and Late-Onset Pompe Disease: An Iranian Consensus.
Fatehi F, Ashrafi MR, Babaee M, Ansari B, Beiraghi Toosi M, Boostani R, Eshraghi P, Fakharian A, Hadipour Z, Haghi Ashtiani B, Moravej H, Nilipour Y, Sarraf P, Sayadpour Zanjani K, Nafissi S. Fatehi F, et al. Among authors: eshraghi p. Front Neurol. 2021 Sep 21;12:739931. doi: 10.3389/fneur.2021.739931. eCollection 2021. Front Neurol. 2021. PMID: 34621239 Free PMC article. Review.
Optimal Frequency to Screen Celiac Disease amongst Patients with Type 1 Diabetes Mellitus: A Multicenter Study.
Moravej H, Zamanfar D, Aghamahdi F, Hashemipour M, Mirrashidi FS, Ghaemi N, Eshraghi P, Ilkhanipoor H, Amirhakimi A, Yazdani N, Asl SN, Hashemian S, Raoofat A, Vazirian MV, Ebrahimzadeh H. Moravej H, et al. Among authors: eshraghi p. Prim Care Diabetes. 2021 Dec;15(6):1100-1103. doi: 10.1016/j.pcd.2021.08.011. Epub 2021 Sep 6. Prim Care Diabetes. 2021. PMID: 34503936
Evaluation of the safety and efficacy of biosimilar recombinant growth hormone in children with growth hormone deficiency: non-inferiority, randomized, parallel, multicentric and Phase III trial.
Zaeri H, Omidvar S, Servatian N, Arefnia S, Khademolreza N, Amini H, Taghavi B, Hashemipour M, Eshraghi P, Ghasemi M, Ghergherehchi R, Maleki E, Moravej H, Noorian S, Soheilipour F, Dalili S, Kharazmi H, Didban A, Akhlaghi A, Ghaznavi S, Shahbazi M. Zaeri H, et al. Among authors: eshraghi p. Expert Opin Drug Saf. 2024 May 8:1-9. doi: 10.1080/14740338.2024.2348576. Online ahead of print. Expert Opin Drug Saf. 2024. PMID: 38682328
Niemann-Pick Diseases: The Largest Iranian Cohort with Genetic Analysis.
Hashemian S, Eshraghi P, Dilaver N, Galehdari H, Shalbafan B, Vakili R, Ghaemi N, Ahangari N, Rezazadeh Varaghchi J, Zeighami J, Sedaghat A, Aminzadeh M, Hamid M, Saberi A, Ashtari F, Ghayoor Karimiani E, Shariati G. Hashemian S, et al. Among authors: eshraghi p. Iran J Child Neurol. 2019 Spring;13(2):155-162. Iran J Child Neurol. 2019. PMID: 31037088 Free PMC article.
Molecular characterization of a large cohort of mucopolysaccharidosis patients: Iran Mucopolysaccharidosis RE-diagnosis study (IMPRESsion).
Ghaffari SR, Rafati M, Shadnoush M, Pourbabaee S, Aghighi M, Mirab Samiee S, Kermanchi J, Alaei MR, Salehpour S, Amirkashani D, Setoodeh A, Sarkhail P, Badv RS, Aminzadeh M, Shiva S, Eshraghi P, Moravej H, Hashemipour M, Rostampour N, Hamidieh AA, Shamsian BS, Shams S, Zamanfar D, Ebrahimi A, Otadi A, Tara SZ, Barati Z, Fakhri L, Hoseini A, Amiri H, Ramandi S, Mostofinezhad N, Kani ZP, Mohammadyari E, Khosravi M, Saadati M, Hoseininasab F, Khorram Khorshid HR, Modaberisaber Y. Ghaffari SR, et al. Among authors: eshraghi p. Hum Mutat. 2022 Apr;43(4):e1-e23. doi: 10.1002/humu.24328. Epub 2022 Feb 3. Hum Mutat. 2022. PMID: 35005816
28 results